What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Cancer
Takayuki Asahara spends much of his time researching Angiogenesis, Progenitor cell, Neovascularization, Immunology and Endothelium.
The various areas that Takayuki Asahara examines in his Angiogenesis study include Endothelial stem cell, Vasculogenesis, Vascular endothelial growth factor A, Vascular endothelial growth factor and Pathology.
His study focuses on the intersection of Endothelial stem cell and fields such as Cell biology with connections in the field of Morphogen.
Takayuki Asahara is interested in Endothelial progenitor cell, which is a field of Progenitor cell.
Takayuki Asahara interconnects Receptor tyrosine kinase and Ischemia in the investigation of issues within Neovascularization.
His research in Immunology intersects with topics in Cancer research and Haematopoiesis.
His most cited work include:
- Isolation of putative progenitor endothelial cells for angiogenesis. (7575 citations)
- Bone Marrow Origin of Endothelial Progenitor Cells Responsible for Postnatal Vasculogenesis in Physiological and Pathological Neovascularization (2978 citations)
- Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. (2250 citations)
What are the main themes of his work throughout his whole career to date?
Takayuki Asahara mostly deals with Progenitor cell, Angiogenesis, Immunology, Vasculogenesis and Cancer research.
His Progenitor cell research integrates issues from Endothelial stem cell, Neovascularization and Bone marrow.
His work deals with themes such as Endocrinology and Ischemia, which intersect with Neovascularization.
His studies in Angiogenesis integrate themes in fields like Vascular endothelial growth factor A, Vascular endothelial growth factor, Endothelium and Blood vessel.
His Immunology research is multidisciplinary, relying on both Ex vivo and Peripheral blood mononuclear cell.
His Vasculogenesis course of study focuses on Transplantation and CD34 and Cardiology.
He most often published in these fields:
- Progenitor cell (51.22%)
- Angiogenesis (31.44%)
- Immunology (33.88%)
What were the highlights of his more recent work (between 2013-2021)?
- Progenitor cell (51.22%)
- Endothelial progenitor cell (23.85%)
- Stem cell (24.66%)
In recent papers he was focusing on the following fields of study:
Takayuki Asahara mainly investigates Progenitor cell, Endothelial progenitor cell, Stem cell, Transplantation and Pathology.
The study incorporates disciplines such as In vivo, Angiogenesis, Bone marrow and Ischemia in addition to Progenitor cell.
His Angiogenesis research incorporates elements of Mesenchymal stem cell and Immunology.
Takayuki Asahara combines subjects such as Wound healing, Tube formation and Peripheral blood mononuclear cell with his study of Endothelial progenitor cell.
Within one scientific family, Takayuki Asahara focuses on topics pertaining to Clinical trial under Transplantation, and may sometimes address concerns connected to Surgery.
His Pathology study combines topics in areas such as CD34 and Regeneration.
Between 2013 and 2021, his most popular works were:
- Pretreatment of Cardiac Stem Cells With Exosomes Derived From Mesenchymal Stem Cells Enhances Myocardial Repair. (116 citations)
- Concise Review: Diabetes, the Bone Marrow Niche, and Impaired Vascular Regeneration (64 citations)
- SDF‐1/CXCR4 Axis in Tie2‐Lineage Cells Including Endothelial Progenitor Cells Contributes to Bone Fracture Healing (51 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
